Gene · 94
Papers4,014
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
581 to 600 of 4,014
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genes in pediatric pulmonary arterial hypertension and the most promising BMPR2 gene therapy. | Front Genet | 2022 | 36506323 | PubTator, text mining | PubMed |
| Brain arteriovenous malformation in hereditary hemorrhagic telangiectasia: Recent advances in cellular and molecular mechanisms. | Front Hum Neurosci | 2022 | 36504622 | PubTator, text mining | PubMed |
| Dickkopf-3: An Update on a Potential Regulator of the Tumor Microenvironment. | Cancers (Basel) | 2022 | 36497305 | PubTator, text mining | PubMed |
| The Role of Bone Morphogenetic Protein Receptor Type 2 (BMPR2) and the Prospects of Utilizing Induced Pluripotent Stem Cells (iPSCs) in Pulmonary Arterial Hypertension Disease Modeling. | Cells | 2022 | 36497082 | PubTator, text mining | PubMed |
| Mitochondrial dysfunction induces ALK5-SMAD2-mediated hypovascularization and arteriovenous malformations in mouse retinas. | Nat Commun | 2022 | 36496409 | PubTator, text mining | PubMed |
| Application of second-generation sequencing in congenital pulmonary airway malformations. | Sci Rep | 2022 | 36443638 | PubTator, text mining | PubMed |
| Case report: Pulmonary arterial hypertension in ENG-related hereditary hemorrhagic telangiectasia. | Front Cardiovasc Med | 2022 | 36440054 | PubTator, text mining | PubMed |
| Endothelial cilia dysfunction in pathogenesis of hereditary hemorrhagic telangiectasia. | Front Cell Dev Biol | 2022 | 36438574 | PubTator, text mining | PubMed |
| Delineating the dynamic evolution from preneoplasia to invasive lung adenocarcinoma by integrating single-cell RNA sequencing and spatial transcriptomics. | Exp Mol Med | 2022 | 36434043 | PubTator, text mining | PubMed |
| Small Non-Coding RNAs as New Biomarkers to Evaluate the Quality of the Embryo in the IVF Process. | Biomolecules | 2022 | 36421701 | PubTator, text mining | PubMed |
| The roles of metabolic profiles and intracellular signaling pathways of tumor microenvironment cells in angiogenesis of solid tumors. | Cell Commun Signal | 2022 | 36419156 | PubTator, text mining | PubMed |
| Vessel state and immune infiltration of the angiogenesis subgroup and construction of a prediction model in osteosarcoma. | Front Immunol | 2022 | 36405691 | PubTator, text mining | PubMed |
| GNAQ mutations drive port wine birthmark-associated Sturge-Weber syndrome: A review of pathobiology, therapies, and current models. | Front Hum Neurosci | 2022 | 36405075 | PubTator, text mining | PubMed |
| Patient-specific and gene-corrected induced pluripotent stem cell-derived endothelial cells elucidate single-cell phenotype of pulmonary veno-occlusive disease. | Stem Cell Reports | 2022 | 36400028 | PubTator, text mining | PubMed |
| Low-grade myofibroblastic sarcoma of the proximal femur: A case report and literature review. | Medicine (Baltimore) | 2022 | 36397412 | PubTator, text mining | PubMed |
| Prognostic and predictive biomarkers for response to neoadjuvant chemoradiation in esophageal adenocarcinoma. | Biomark Res | 2022 | 36376989 | PubTator, text mining | PubMed |
| Combining genetic constraint with predictions of alternative splicing to prioritize deleterious splicing in rare disease studies. | BMC Bioinformatics | 2022 | 36376793 | PubTator, text mining | PubMed |
| Macrophages in health and disease. | Cell | 2022 | 36368305 | PubTator, text mining | PubMed |
| Rosai-Dorfman Disease between Proliferation and Neoplasia. | Cancers (Basel) | 2022 | 36358690 | PubTator, text mining | PubMed |
| Five years' experience of the clinical exome sequencing in a Spanish single center. | Sci Rep | 2022 | 36357507 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/94/papers?page=30